About Isolation Bio
Isolation Bio is a Healthcare company based in San Carlos (United States) founded in 2014 by Michael Seely, Roman Stocker, and Paul Blainey. It operates as a microbial isolation and cultivation devices are developed for research. Isolation Bio has raised $38.53 million across 6 funding rounds. Isolation Bio offers products and services including Prospector Discovery Platform and Microbial Isolation Service. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Microbiomics. Its legal entity is Isolation Bio, Inc. Its competitors include C4Diagnostics, Gosselin, Bio Quick, BioSense Solutions and Systems and Synthetic Biology and 4 more; 1 of its 9 listed competitors has raised funding.
Company details
Isolation Bio was founded in 2014 and is headquartered in San Carlos, United States. Devices for microbial isolation and cultivation are developed within the biotechnology sector. The Prospector discovery platform is provided, supporting parallel cultivation of microcolonies via high-throughput, scalable array technology. Operations emphasize research applications in microbiology, with tools designed for efficient scientific workflows across laboratory settings.
- Headquarters San Carlos, United States
- Founders Michael Seely, Roman Stocker, Paul Blainey
- SectorsHealthcare
- Email••••••••
- Website isolationbio.com
- Social LinkedIn X
- Legal Name Isolation Bio, Inc.
- Total Equity Funding$38.53M (USD)
in 6 rounds
- Latest Funding Round$14.46M (USD), Series B
Dec 2020
Products & Services of Isolation Bio
Isolation Bio offers a comprehensive portfolio of products and services, including Prospector Discovery Platform and Microbial Isolation Service.
Platform for high-throughput isolation and screening of microbes.
Custom service for processing samples to deliver research-ready isolates.
Funding Insights of Isolation Bio
Isolation Bio has successfully raised a total of $38.53M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $14.46 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $38.53M
- Total Rounds 6
- Last Round Series B — $14.46M
All 6 funding rounds of Isolation Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2020 | $14.46M | Series B | – | – | – |
| Apr 2020 | $7.72M | Series A | – | – | – |
| Apr 2020 | – | Debt – Conventional | – | – | – |
| Aug 2018 | $10.51M | Series A | – | – | – |
| May 2017 | – | Debt – Conventional | – | – | – |
| May 2017 | $5.84M | Series A | – | – | – |
People of Isolation Bio
3 people are tracked at Isolation Bio (3 in leadership).
| Name | Role | Group |
|---|---|---|
Michael Seely | Co-Founder | Leadership |
Roman Stocker | Co-Founder | Leadership |
Paul Blainey | Co-Founder | Leadership |
Complete people profiles for Isolation Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Isolation Bio
3 dated milestones of Isolation Bio across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Isolation Bio is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $14.5M.
Competitors of Isolation Bio
Isolation Bio has 9 listed competitors in our database, 1 of them funded. They include C4Diagnostics, Gosselin, Bio Quick, BioSense Solutions and Systems and Synthetic Biology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| c4diagnostics.com | 2017 | Marseille, France | $1.75M | – | Provider of technology for detection and count of microorganisms | |
| gosselin.eu | 1965 | Hazebrouck, France | – | – | Manufacturer of laboratory consumables | |
| bio-quick.com | 2004 | Rockville, United States | – | – | Offers charged microscopic slides for quality control in laboratories. | |
| biosensesolutions.dk | 2017 | Farum, Denmark | – | – | Provides automated tools for microbial imaging and analysis in scientific fields. | |
| cholab.or.kr | 2014 | Daejeon, South Korea | – | – | Develops innovative synthetic biology products through microbial engineering. | |
| citotest.com | 2002 | Diqing Tibetan Autonomous Prefecture, China | – | – | Citotest Labware Manufacturing produces and supplies laboratory consumables for scientific and medical use. | |
| flmedical.com | 1979 | Torreglia, Italy | – | – | Produces laboratory disposables like blood collection systems and test tubes. | |
| humanetechnologies.co.uk | 2018 | Coventry, United Kingdom | – | – | Online platform offering informative articles on health, beauty, and daily life. | |
| metis-biotech.com | 2000 | Panazol, France | – | – | Microbiological analysis solutions are developed using flow cytometry for automation. |
Detailed competitors of Isolation Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Isolation Bio (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Isolation Bio
Complete news archive for Isolation Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Isolation Bio
Isolation Bio was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Isolation Bio is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
Isolation Bio is a funded company, having raised a total of $38.53M across 6 funding rounds to date.
Isolation Bio was founded in 2014 and is headquartered in San Carlos, United States. Devices for microbial isolation and cultivation are developed within the biotechnology sector. The Prospector discovery platform is provided, supporting parallel cultivation of microcolonies via high-throughput, scalable array technology. Operations emphasize research applications in microbiology, with tools designed for efficient scientific workflows across laboratory settings.
Isolation Bio's top competitors include C4Diagnostics, Gosselin and METIS.
Isolation Bio offers Prospector Discovery Platform and Microbial Isolation Service.
Isolation Bio operates through Isolation Bio, Inc..